Hyderabad (Telangana) [India], April 13 (ANI): Dr Reddy's Laboratories said on Tuesday it has received permission from the Drug Controller General of India (DCGI) to import Sputnik vaccine into India for restricted use in emergency situations.
New Delhi [India], April 12 (ANI): Russia's Sputnik V got approval from the Subject expert committee (SEC) for Emergency Use Authorisation (EUA), making it the third Covid-19 vaccine to get clearance in India.
New Delhi [India], April 12 (ANI): The Subject Expert Committee (SEC) is likely to meet today to take up Sputnik V application for Emergency Use Authorisation (EUA) in India, said sources.
New Delhi [India], April 1 (ANI): Russia's COVID-19 Sputnik V vaccine was denied emergency use authorisation in India on Thursday by the Subject Expert Committee (SEC) constituted by the central government.
New Delhi [India], March 31 (ANI): Meeting of Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) will be held on Wednesday to deliberate on emergency use authorisation application of Russian vaccine Sputnik V.
Washington DC [US], March 10 (ANI): 340 different coronavirus tests have so far won emergency use authorisation (EUA), including one that can be used at home without a prescription to detect the virus, the Food and Drug Administration (FDA) has said.
Washington [US], February 24 (ANI): The US Food and Drug Administration said on Wednesday that Johnson and Johnson's single-dose COVID-19 vaccine has met the requirements for emergency use authorisation.
Hyderabad (Telangana) [India], Feb 19 (ANI): Dr Reddy's Laboratories said on Friday it has initiated the process with the Drugs Controller General of India (DCGI) for emergency use authorisation of human adenoviral vector-based platform vaccine candidate Sputnik V.
New Delhi [India] February 5 (ANI): The subject expert panel of Drugs Controller General of India did not recommend granting emergency use authorisation to Pfizer's COVID-19 vaccine noting that the firm has not proposed plans to generate safety and immunogenicity data concerning Indian popu
New Delhi [India], January 12 (ANI): Covishield and Covaxin, the two COVID-19 vaccines which have received Emergency Use Authorisation (EAU) have been tested on thousands of people and side-effects are negligible, Dr VK Paul, Member (Health), NITI Aayog, said on Tuesday and noted that the
New Delhi [India], January 12 (ANI): Union Health Secretary Rajesh Bhushan on Tuesday said the COVID-19 vaccine may cost in the range of Rs 200 to 295 in India and two vaccines -- Covishield and Covaxin -- have received Emergency Use Authorisation (EAU) after going through established saf
Moscow [Russia], January 7 (ANI): The Russian Direct Investment Fund (RDIF) on Wednesday announced that Bolivia's State Agency for Medicines and Health Technologies has registered Sputnik V Covid-19 vaccine under emergency use authorisation procedure.